Home›India›AYUSH›Pharmacopoeia Commission for Indian Medicine & Homoeopathy C...
Date: 2026-05-22Category: Press ReleaseState: Union GovernmentCountry: India
Pharmacopoeia Commission for Indian Medicine & Homoeopathy Concludes 5-Day Capacity Building Training Program for ASU&H Drug Regulators and Stakeholders
**Executive Summary**
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) conducted a five-day Capacity Building Training Program in New Delhi from May 18 to 22, 2026. The program aimed to strengthen regulatory knowledge, technical competencies, and quality assurance for 28 participants from the Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) sectors. The initiative combined theoretical lectures with laboratory training and industry visits to enhance the national quality assurance system.
**Key Points / Main Content**
**Program Objectives and Participation**
* Strengthened regulatory understanding and technical capabilities within the ASU&H drug sector.
* Promoted quality assurance mechanisms among drug enforcement officers and manufacturers.
* Engaged 28 participants from regulatory bodies, research councils, pharmaceutical industries, and academic institutions.
**Technical Training and Laboratory Sessions**
* Conducted hands-on training in Pharmacognosy and Chemistry laboratories.
* Focused on pharmacognostic identification and phytochemical analysis of ASU&H drugs.
* Provided sessions on microbiological evaluation and pharmacological studies.
* Covered the standardization of metal and mineral-based drugs.
**Regulatory Frameworks and Industry Exposure**
* Delivered lectures on Good Manufacturing Practices (GMP) and shelf-life studies.
* Facilitated practical exposure to industry practices and quality systems through site visits.
* Visited Dr. Willmar Schwabe India Pvt. Ltd. and Hamdard Laboratories for field exposure.
* Enhanced understanding of pharmacopoeial standards and existing regulatory frameworks.
**Impact Analysis**
**Drug Enforcement Officers and Quality Control Personnel**
**Impact**
They gained a deeper understanding of regulatory frameworks, pharmacopoeial standards, and technical laboratory procedures essential for drug enforcement.
**Action Required**
Apply enhanced technical knowledge and regulatory understanding to strengthen drug enforcement and quality control monitoring.
**ASU&H Drug Manufacturers**
**Impact**
Manufacturers gained practical exposure to industry-standard quality systems, GMP, and the technical requirements for drug standardization.
**Action Required**
Implement improved Good Manufacturing Practices (GMP) and quality assurance protocols within their production facilities.
**Research Councils and Academic Institutions**
**Impact**
Participants from these bodies updated their knowledge on pharmacological studies, phytochemical analysis, and standardization techniques.
**Action Required**
Incorporate contemporary pharmacopoeial standards and technical methodologies into ongoing research and academic training programs.
Key Entities Referenced
Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H): A subordinate office under the Ministry of Ayush responsible for developing pharmacopoeial standards for ASU&H drugs and the primary organizer of the training program.
Ministry of Ayush: The central government ministry responsible for policy formulation and development of the Ayurveda, Yoga, Unani, Siddha, and Homoeopathy sectors.
Capacity Building Training Program for ASU&H Drug Regulators and Stakeholders: A five-day initiative aimed at strengthening regulatory understanding, technical capabilities, and quality assurance mechanisms for ASU&H drug enforcement and manufacturing.
Good Manufacturing Practices (GMP): The regulatory standards for ensuring quality in drug production, which served as a core focus of the training sessions for ASU&H stakeholders.
National Commission for Indian System of Medicine (NCISM): The statutory body regulating medical education and practice in Indian systems of medicine, whose leadership participated in the program's oversight.
AYUSH
Pharmacopoeia Commission for Indian Medicine
& Homoeopathy Concludes 5-Day Capacity
Building Training Program for ASU&H Drug
Regulators and Stakeholders
Program strengthens regulatory knowledge, quality standards
and technical competencies in ASU&H sector
Posted On: 22 MAY 2026 7:30PM by PIB Delhi
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), under the Ministry of
Ayush, successfully concluded a five-day Capacity Building Training Program for Drug Enforcement
Officers, Quality Control Personnel and manufacturers of Ayurveda, Siddha, Unani and Homoeopathy
(ASU&H) drugs today in New Delhi.
The training programme was organized from May 18 to 22, 2026, with the objective of strengthening
regulatory understanding, enhancing technical capabilities and promoting quality assurance mechanisms
in the ASU&H drug sector.A total of 28 participants from regulatory bodies, research councils,
pharmaceutical industries and academic institutions across the country attended the programme.The first two days of the programme featured technical sessions on pharmacognostic identification of
ASU&H drugs, phytochemical analysis and Good Manufacturing Practices (GMP), along with hands-on
laboratory training in Pharmacognosy and Chemistry laboratories.
On the third day, lectures were delivered on shelf-life studies and regulatory frameworks. Participants also
undertook industry visits to Dr. Willmar Schwabe India Pvt. Ltd. and Hamdard Laboratories for practical
exposure to industry practices and quality systems.
The fourth day included sessions on microbiological evaluation and regulatory aspects, accompanied by
practical laboratory training. The final day focused on pharmacological studies, GMP and standardization
of metal and mineral-based drugs.
The inaugural session was graced by Jaspal Kaur Pradyot, Chief Controller of Accounts, Ministry of
Health & Family Welfare, as the Chief Guest. Abdul Qayum, Director (Technical) & Deputy CEO,
National Medicinal Plants Board, Ministry of Ayush, attended the event as the Guest of Honour. Raman
Mohan Singh, Director, PCIM&H, welcomed the dignitaries and participants.The valedictory session was graced by Maneesha Upendra Kothekar, Chairperson, National Commission
for Indian System of Medicine, as the Chief Guest and Pramod Kumar Pathak, Principal Consultant &
Retd. Special Secretary, Ministry of Ayush, as the Guest of Honour.
The programme served as a comprehensive platform combining expert lectures, practical laboratory
training and field exposure. It significantly enhanced participants’ understanding of pharmacopoeial
standards, GMP and regulatory frameworks, thereby contributing towards strengthening the quality
assurance system for ASU&H drugs in the country.
***
SR/SV/SG
(Release ID: 2264306) Visitor Counter : 936
Read this release in: Urdu , ही , Tamil